Activated peripheral blood mononuclear cells induce p44/42 mitogen-activated protein kinase phosphorylation in trophoblast-like JAR cells

Journal of Reproductive Immunology

Volumn 60, Issue 2, 2003, Pages 113-128

  Jiang, Kaiyu ^a   Chen, Yanmin ^a   Jarvis, James N ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

JAR cells; Mitogen activated protein kinase; Mononuclear cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; INTERLEUKIN 2; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; BLOOD CELL; CARCINOMA CELL; CELL ACTIVATION; CELL CULTURE; CHORIOCARCINOMA; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOLYSIS; ENZYME ACTIVITY; FETUS (ANATOMY); GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEASUREMENT; MONONUCLEAR CELL; MOTHER FETUS RELATIONSHIP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; TISSUE; TROPHOBLAST; WESTERN BLOTTING;

EID: 0345293235     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(03)00111-6     Document Type: Article

References (44)

1. Arbabi S., Maier R.V. Mitogen activated protein kinases. Crit. Care Med. 30:2002;S74-S79.
2. Bainbridge D.R. Evolution of mammalian pregnancy in the presence of the maternal immune system. Rev. Reprod. 5:2000;67-74.
3. Chang W.K., Yang K.D., Chuang H., Jan J.T., Shaio M.F. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin. Immunol. 104:2002;151-160.
4. Chaouat G., Cayol V., Mairovitz V., Dubanchet S. Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the fetomaternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy. Am. J. Reprod. Immunol. 42:1999;1-13.
5. Coulam C.B. Understanding the immunobiology of pregnancy and applying it to treatment of recurrent pregnancy loss. Early Pregnancy. 4:2000;19-29.
6. Coumans B., Thellin O., Zorzi W., Melot F., Bougoussa M., Melen L., Zorzi D., Hennen G., Igout A., Heinen E. Lymphoid cell apoptosis induced by trophoblastic cells: a model of active foeto-placental tolerance. J. Immunol. Methods. 224:1999;185-196.
7. Das C., Kumar V.S., Gupta S., Kumar S. Network of cytokines, integrins and hormones in human trophoblast cells. J. Reprod. Immunol. 53:2002;257-268.
8. Desai J., Holt-Shore V., Torry R.J., Caudle M.R., Torry D.S. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol. Reprod. 60:1999;887-892.
9. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltier A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. (USA). 92:1995;7686-7689.
10. Gleeson L.M., Chakraborty C., McKinnon T., Lala P.K. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J. Clin. Endocrinol. Metab. 86:2001;2484-2493.
11. Gobin S.J., Wilson L., Keijsers V., Van den Elsen P.J. Antigen processing and presentation by human trophoblast-derived cell lines. J. Immunol. 158:1997;3587-3592.
12. Guilbert L., Robertson S.A., Wegman T.G. The trophoblast as an integral component of a macrophage-cytokine network. Immunol. Cell Biol. 71:1993;49-57.
13. Guleria I., Pollard J.W. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 6:2000;589-593.
14. Hammer A., Blaschitz A., Daxbock C., Walcher W., Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am. J. Reprod. Immunol. 41:1999;41-51.
15. Hammar A., Hartmann M., Sedlmayr P., Walcher W., Kohnen G., Dohr G. Expression of Fas ligand in choriocarcinoma. Am. J. Reprod. Immunol. 48:2002;226-234.
16. Hill J.A., Choi B.C. Maternal immunological aspects of pregnancy success and failure. J. Reprod. Fertil.-Suppl. 55:2000;91-97.
17. Jarvis J.N., Deng L., Moore H.T., Berry S., Romero R. Expression of fetal cytokine mRNA in utero using reverse transcriptase polymerase chain reaction. Pediatr. Res. 37:1995;450-454.
18. Jarvis J.N., Zhao L., Moore H.T., Gutta V., Long P.M. Regulation of cytokine mRNA expression in activated lymphocytes by human choriocarcinoma cells. Cell Immunol. 168:1996;251-257.
19. Johnson P.M. Immunobiology of the human placental trophoblast. Exp. Clin. Immunogenet. 10:1993;118-122.
20. Kang S.K., Tai C.J., Cheng K.W., Leung P.C. Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells. Mol. Cell. Endocrinol. 170:2000;143-151.
21. Kauma S.W., Huff T.F., Hayes N., Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J. Clin. Endocrinol. Metab. 84:1999;2188-2194.
22. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:2000;289-305.
23. Liao C.L., Lin Y.L., Wang J.J., Huang Y.L., Yeh C.T., Ma S.H., Chen L.K. Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J. Virol. 71:1997;5963-5971.
24. Loke Y.W., King A. Immunology of implantation. Best Pract. Res. Clin. Obstetr. Gynaecol. 14:2000;827-837.
25. McKinnon T., Chakraborty C., Gleeson L.M., Chidiac P., Lala P.K. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J. Clin. Endocrinol. Metab. 86:2001;3665-3674.
26. Obata T., Brown G.E., Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit. Care Med. 28:2000;N67-N77.
27. Ohshima K., Nakashima M., Sonoda K., Kikuchi M., Watanabe T. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin. Exp. Immunol. 123:2001;481-486.
28. Pearson G., Robinson F., Gibson T.B., Xu B.-E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiologic function. Endocr. Rev. 22:2001;153-183.
29. Peyman J.A., Hammond G.L. Localization of IFN-gamma receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-gamma. J. Immunol. 149:1992;2675-2680.
30. Phillips T.A., Ni J., Pan G., Ruben S.M., Wei Y.F., Pace J.L., Hunt J.S. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol. 162:1999;6053-6059.
31. Rieger L., Kammerer U., Hofmann J., Sutterlin M., Dietl J. Choriocarcinoma cells modulate the cytokine production of decidual large granular lymphocytes in coculture. Am. J. Reprod. Immunol. (Copenhagen). 46:2001;137-143.
32. Rodriguez A.M., Mallet V., Lenfant F., Arnaud J., Girr M., Urlinger S., Bensussan A., Le Bouteiller P. Interferon-gamma rescues HLA class Ia cell surface expression in term villous trophoblast cells by inducing synthesis of TAP proteins. Eur. J. Immunol. 27:1997;45-54.
33. Rogers A.M., Boime I., Connolly J., Cook J.R., Russell J.H. Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand. Eur. J. Immunol. 28:1998;3479-3487.
34. Saito S. Cytokine network at the feto-maternal interface. J. Reprod. Immunol. 47:2000;87-103.
35. Saleem M.A., Jha P., Buckshee K., Farooq A. Studies on mitogen-induced lymphocyte transformation and the effect of pregnancy serum on mitogen-induced normal lymphocyte culture. Gynecol. Obstet. Invest. 33:1992;9-14.
36. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
37. Steele A., Uckan D., Steele P., Chamizo W., Washington K., Koutsonikolis A., Good R.A. RT in situ PCR for the detection of mRNA transcripts of Fas-L in the immune-privileged placental environment. Cell Vis. 5:1998;13-19.
38. Taniguchi T., Matsuzaki N., Jo T., Saji F., Taga T., Hirano T., Kishimoto T., Tanizawa O. Interleukin-1 (IL-1)-induced IL-6- and IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3′,5′-monophosphate-independent signal transduction pathway. J. Clin. Endocrinol. Metab. 74:1992;1389-1395.
39. Torry D.S., McIntyre J.A., Faulk W.P. Immunobiology of the trophoblast: mechanisms by which placental tissues evade maternal recognition and rejection. Curr. Topics Microbiol. Immunol. 222:1997;127-140.
40. Uckan D., Steele A., Wang B.Y., Chamizo W., Koutsonikolis A., Gilbert-Barness E., Good R.A. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3:1997;655-662.
41. Vanderbeeken Y.E., Duchateau J., Gregoire M., Vandermeersch B., Collett H., Lucas A. Modulation of B cell stimulation by maternal serum. Immunol. Invest. 20:1991;287-304.
42. Wegman T.G., Guilbert L.J. Immune signaling at the maternal-fetal interface and trophoblast differentiation. Dev. Comp. Immunol. 16:1992;425-430.
43. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 287:2000;498-501.
44. Zorzi W., Thellin O., Coumans B., Melot F., Hennen G., Lakaye B., Igout A., Heinen E. Demonstration of the expression of CD95 ligand transcript and protein in human placenta. Placenta. 19:1998;269-277.